Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B

Drug Delivery

Volumn 23, Issue 8, 2016, Pages 3101-3110

  Hussain, Afzal ^a   Singh, Vikas Kumar ^b   Singh, Om Prakash ^b   Shafaat, Kausar ^b   Kumar, Sanjay ^b   Ahmad, Farhan Jalees ^c  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

^b S Sinha College   (India)

^c HAMDARD UNIVERSITY   (India)

Author keywords

Amphotericin B; confocal laser scanning microscopy; nanoemulsion; penetration; topical delivery

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; BUFFER; EXCIPIENT; LABRASOL; LIPID; MACROGOL 400; OCTANOIN; SURFACTANT; ANTIFUNGAL AGENT; DRUG CARRIER; EMULSION; NANOPARTICLE;

ANIMAL EXPERIMENT; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; CANDIDA ALBICANS; CELLS; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; CREAM; DISPERSITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG SOLUTION; DRUG STABILITY; EX VIVO STUDY; FRANZ DIFFUSION CELL; FUNGAL STRAIN; IN VITRO STUDY; INHIBITION ZONE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RAT; SKIN PENETRATION; STRATUM CORNEUM; SUSTAINED DRUG RELEASE; TITRIMETRY; ZETA POTENTIAL; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; DRUG EFFECTS; EMULSION; FEMALE; MALE; MEDICINAL CHEMISTRY; METABOLISM; PROCEDURES; SKIN; SKIN ABSORPTION;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; EXCIPIENTS; FEMALE; LIPIDS; MALE; NANOPARTICLES; PARTICLE SIZE; RATS; SKIN; SKIN ABSORPTION; SURFACE-ACTIVE AGENTS;

EID: 84961201746     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2016.1153747     Document Type: Article

References (29)

1. Ahmed M, Ramadan W, Rambhu D, Shakeel F., (2008). Potential of nanoemulsions for intravenous delivery of rifampicin. Pharmazie 63:806–11
2. Attwood D, Mallon D, Taylor CJ. (1992). Phase studies on oil in water microemulsions. Int J Pharm 8:R5–8
3. Azeem A, Rizwan M, Ahmad FJ, et al. (2009). Nanoemulsion components screening and selection:a technical note. AAPS PharmSciTech 10:69–76
4. Chang SC, Lin SJ, Chen TW, Lin YT., (2012). A biocide-free mineral oil nanoemulsion exhibiting strong bactericidal activity against Mycobacterium immunogenum and Pseudomonas aeruginosa. Int Biodeter Biodegr 70:66–73
5. Chen H, Chang X, Du D, et al. (2006). Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release 110:296–306
6. Espuelas MS, Legrand P, Irache JM, et al. (1997). Poly(ɛ-caprolacton) nanospheres as an alternative way to reduce amphotericin B toxicity. Int J Pharm 158:19–27
7. Fukui H, Koike T, Nakagawa T, et al. (2003a). Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations. Int J Pharm 267:101–12
8. Fukui H, Koike T, Saheki A, et al. (2003b). Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS). Int J Pharm 263:51–60
9. Glavas-Dodov M, Fredro-Kumbaradzi E, Goracinova K, et al. (2005). The effects of lyophilization on the stability of liposomes containing 5-FU. Int J Pharm 291:79–86
10. Hussain A, Haque MW, Singh SK, Ahmed FJ., (2015). Optimized permeation enhancer for topical delivery of 5-fluorouracil-loaded elastic liposome using Design Expert:part II. Drug Deliv. [Epub ahead of print]. DOI:10.3109/10717544.2015.1124473
11. Hussain A, Samad A, Nazish I, Ahmed FJ., (2013). Nanocarrier-based topical drug delivery for an antifungal drug. Drug Dev Ind Pharm 40:527–41
12. Hussain A, Samad A, Singh SK, et al. (2014a). Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B. Drug Dev Ind Pharm 41:780–90
13. Hussain A, Samad A, Singh SK, et al. (2014b). Nanoemulsion gel-based topical delivery of an antifungal drug:in vitro activity and in vivo evaluation. Drug Deliv 23:652–67
14. Hussain A, Samad A, Ramzan M, et al. (2016). Elastic liposome-based gel for topical delivery of 5-fluorouracil:in vitro and in vivo investigation. Drug Deliv. [Epub ahead of print]. DOI:10.3109/10717544.2014.976891
15. Hussain A, Singh SK., (2016). Evidences for anti-mycobacterium activities of lipids and surfactants. World J Microbiol Biotechnol 32:7. doi:10.1007/s11274-015-1965-4
16. Jain SK, Gupta Y, Jain A, Rai K., (2008). Enhanced transdermal delivery of acyclovir sodium via elastic liposomes. Drug Deliv 15:141–7
17. Joe MM, Bradeeba K, Parthasarathi R, et al. (2012). Development of surfactin-based nanoemulsion formulation from selected cooking oils:evaluation for antimicrobial activity against selected food associated microorganisms. J Taiwan Inst Chem Eng 43:172–80
18. Kadimi US, Balasubramanian DR, Ganni UR, et al. (2007). In vitro studies on liposomal amphotericin B obtained by supercritical carbon dioxide-mediated process. Nanomedicine 3:273–80
19. Kalhapure RS, Suleman N, Mocktar C, et al. (2015). Nanoengineered drug delivery systems for enhancing antibiotic therapy. J Pharm Sci 104:872–905
20. Kleinberg M., (2006). What is the current and future status of conventional amphotericin B? Int J Antimicrob Agents 27S:S12–6
21. Nahar M, Mishra D, Dubey V, Jain NK., (2008). Development, characterization and toxicity evaluation of amphotericin B-loaded nanogelatin nanoparticles. Nanomedicine 4:252–61
22. Ouellette M, Drummelsmith J, Papadopoulou B. (2004). Leishmaniasis:drugs in the clinic, resistance and new developments. Drug Resist Updat 7:257–66
23. Sarker SD, Nahar L, Kumarasamy Y., (2007). Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals. Methods 42:321–4
24. Shafaat K, Kumar B, Das SK, et al. (2013). Novel nanoemulsion as vehicle for transdermal delivery of clozepine in vitro and in vivo studies. Int J Pharm Pharm Sci 5:126–34
25. Singh N, Verma SM, Singh SK, Verma PR., (2015). Evidence for bactericidal activities of lipidic nanoemulsions against Pseudomonas aeroginosa. Antonie Van Leeuwenhoek 107:1555–68
26. Teichmann A, Heuschkel S, Jacobi U, et al. (2007). Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream. Eur J Pharm Biopharm 67:699–706
27. Utreja P, Jain S, Tiwar AK., (2011). Localized delivery of paclitaxel using elastic liposomes:formulation development and evaluation. Drug Deliv 18:367–76
28. Wissing SA, Lippacher A, Müller RH., (2001). Investigations on the occlusive properties of solid lipid nanoparticles (SLN). J Cosmet Sci 52:313–23
29. Wong-Beringer A, Jacobs RA, Guglielmo BJ., (1998). Lipid formulations of amphotericin B:clinical efficacy and toxicities. Clin Infect Dis 27:603–18